Medical Communications

Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …

Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical …

Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …

The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …

Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen’s EMEA operations to discuss nearly three decades at the …

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …

Prostate cancer has begun to receive more publicity in recent years in the UK, but not for the right reasons. …

Shortly after the Institute for Safe Medication Practices released a report revealing the number of deaths of patients in those …

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …

A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …

Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …

Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …